Smoking-Related Health Risks Among Persons With HIV in the Strategies for Management of Antiretroviral Therapy Clinical Trial
October 19, 2010
Smoking prevalence is higher among HIV-positive persons than among the general population. In the current study, the researchers sought to determine smoking-related hazard ratios (HRs) and population-attributable risk (PAR) percentage for serious clinical events and death among HIV-positive persons.
For 5,472 HIV-positive persons enrolled from 33 countries in the Strategies for Management of Antiretroviral Therapy (SMART) clinical trial, the team evaluated the relationship between baseline smoking status, development of AIDS-related or serious non-AIDS events, and overall mortality.
American Journal of Public Health
10.2010; Vol. 100; No. 10: P. 1896-1903; Alan R. Lifson, MD, MPH; Jacqueline Neuhaus, MS; Jose Ramon Arribas, MD; Mary van den Berg-Wolf, MD; Ann M. Labriola, MD; Timothy R.H. Read, MBBS; and the INSIGHT SMART Study Group
Connecting Discovery and Delivery: The Need for More Evidence on Effective Smoking Cessation Strategies for People Living With HIV/AIDS
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
Add Your Comment:
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)